NIH-funded research NIH-funded research

Evaluating vaccines to prevent HIV using nonhuman primates

Official title: Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support

Funded at Bioqual, INC. · NIH-11060166 · Data updated 2026-11-12

This study is testing new HIV vaccines using monkeys to see how well they work and how they help the immune system, with the goal of finding effective ways to prevent or control HIV for everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBioqual, INC.
NIH-funded
Lab location1 site (Rockville, United States)
Project startApril 1, 2020
Project endMarch 31, 2027
Funding year2024
Award (this year)$439,740
NIH project number75N93020D00006-P00004-759302000001-1
Project IDNIH-11060166 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at high risk for HIV who may benefit from new prevention strategies.

Less likely to help

Patients who are already HIV positive or those who do not have a risk of HIV exposure may not benefit from this research.

What this research studies

This research focuses on the evaluation of potential HIV vaccines through the use of nonhuman primates (NHPs) in preclinical studies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for testing candidate AIDS vaccines, allowing researchers to assess immune responses and vaccine efficacy. By conducting thorough evaluations, the program aims to identify effective strategies for preventing or controlling HIV infection. The SVEUs support all stages of AIDS vaccine research, from initial evaluations to clinical testing.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective vaccines that significantly reduce the risk of HIV infection.

How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach is both tested and potentially effective.

Where this research is happening

  • Bioqual, INC.
    Rockville, United States
    Active

Researchers

  • Principal investigator: Lewis, Mark — Bioqual, INC.
  • Study coordinator: Lewis, Mark

Related research

Other NIH-funded projects on the same topics.

  • Developing models to understand infectious diseases.

    This study is working on building models that mimic infectious diseases to help researchers find better ways to treat them, which could lead to new and improved options for patients like you.

    NIH research Bioqual, INC. · Rockville, United States · NIH-11197698

  • Developing models to understand infectious diseases.

    This study is working on creating models that mimic infectious diseases to help researchers find better treatments, which could eventually lead to improved therapies for patients dealing with these illnesses.

    NIH research Bioqual, INC. · Rockville, United States · NIH-11197632

  • Evaluating vaccines for HIV using nonhuman primates

    This study is looking at how well different HIV vaccines and prevention methods work using nonhuman primates, with the goal of finding effective ways to stop or control HIV infection.

    NIH research Bioqual, INC. · Rockville, United States · NIH-11060169

  • Using a virus to deliver antibodies that protect against SIV infection

    This study is looking at a new way to help protect against the Simian Immunodeficiency Virus (SIV) by using special antibodies delivered through a harmless virus, and it's being tested in nonhuman primates to find better strategies for future HIV vaccines and treatments.

    NIH research Bioqual, INC. · Rockville, United States · NIH-10927011

  • Evaluating vaccines for HIV using nonhuman primates

    This study is looking at how well potential vaccines and prevention methods for HIV/AIDS work using nonhuman primates, helping researchers find effective ways to protect people from the virus.

    NIH research Bioqual, INC. · Rockville, United States · NIH-10817651

  • Evaluating vaccines for HIV prevention using nonhuman primates

    This study is working on creating better vaccines for HIV by testing them in monkeys first, to see how well they can help the immune system fight the virus before they are used in people.

    NIH research Bioqual, INC. · Rockville, United States · NIH-10817650

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.